81 related articles for article (PubMed ID: 364731)
1. Enhancement of nonspecific host defenses against local bacterial challenge.
Rouben DP; Fagelman K; McCoy MT; Polk HC
Surg Forum; 1977; 28():44-5. PubMed ID: 364731
[No Abstract] [Full Text] [Related]
2. Simulated surgical wound infection in mice: effect of stimulation on nonspecific host defense mechanisms.
Fagelman KM; Flint LM; McCoy MT; Polk HC; Trachtenberg LS
Arch Surg; 1981 Jun; 116(6):761-4. PubMed ID: 7016070
[TBL] [Abstract][Full Text] [Related]
3. Immunoprophylaxis and immunotherapy of Gram-negative infections in the immunocompromised host.
Glauser MP; McCutchan JA; Ziegler E
Clin Haematol; 1984 Oct; 13(3):549-55. PubMed ID: 6388931
[TBL] [Abstract][Full Text] [Related]
4. [Sepsis in newborn infants in a surgical clinic].
Krasovskaia TV; Kobzeva TN; Romanova LA; Samsygin SA; Dolgina EN
Vestn Khir Im I I Grek; 1981 Jun; 126(6):109-12. PubMed ID: 7269127
[No Abstract] [Full Text] [Related]
5. Immunostimulation and host resistance against infection: therapeutic perspectives.
Fauve RM
Adv Nephrol Necker Hosp; 1980; 9():167-86. PubMed ID: 6157316
[No Abstract] [Full Text] [Related]
6. Infections in neurologic surgery. Host defenses.
Borges LF
Neurosurg Clin N Am; 1992 Apr; 3(2):275-8. PubMed ID: 1633459
[TBL] [Abstract][Full Text] [Related]
7. Preventing anaerobic infection in surgery of the colon.
Lewis RT; Allan CM; Goodall RG; Lloyd-Smith WC; Marien B; Park M; Wiegand FM
Can J Surg; 1981 Mar; 24(2):139-41, 184. PubMed ID: 7013957
[TBL] [Abstract][Full Text] [Related]
8. A comparison of topical and systemic cefazolin for wound prophylaxis.
Scher KS; Jones CW; Wroczynski AF
Surg Gynecol Obstet; 1984 Feb; 158(2):117-9. PubMed ID: 6364425
[TBL] [Abstract][Full Text] [Related]
9. Levamisole synergizes proliferation of intestinal IgA+ cells in weaned pigs immunized with vaccine candidate F4ac+ nonenterotoxigenic Escherichia coli strain.
Janjatović AK; Lacković G; Bozić F; Popović M; Valpotić I
J Vet Pharmacol Ther; 2008 Aug; 31(4):328-33. PubMed ID: 18638293
[TBL] [Abstract][Full Text] [Related]
10. [Suppurative surgical infection in newborn infants and the clinico-immunological effect of using dekaris].
Samsygin SA; Dolgina EN; Romanova LA; Shevochkina GI; Ovchinnikova EA
Khirurgiia (Mosk); 1986 Aug; (8):21-6. PubMed ID: 3761926
[No Abstract] [Full Text] [Related]
11. Developments in immunotherapy.
Krakowka S
Mod Vet Pract; 1981 Jun; 62(6):447-51. PubMed ID: 6166843
[TBL] [Abstract][Full Text] [Related]
12. Cancer immunotherapy.
Richman SP; Gutterman JU; Hersh EM
Can Med Assoc J; 1979 Feb; 120(3):322-4, 329. PubMed ID: 371776
[TBL] [Abstract][Full Text] [Related]
13. Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections.
Grimaldi GF; Moriearty PL; Hoff R
Clin Exp Immunol; 1980 Aug; 41(2):237-42. PubMed ID: 7438553
[TBL] [Abstract][Full Text] [Related]
14. [Blood transfusion and risk of surgical infection].
Kristensen T; Jacobsen SE; Lillevang ST; Georgsen J
Ugeskr Laeger; 1993 Dec; 155(51):4196-7. PubMed ID: 8273253
[No Abstract] [Full Text] [Related]
15. Staphylococcal lysate fails to elicit nonspecific immune enhancement in a simulated surgical infection.
Brown GL; Cobb JP; Brown CM; Polk HC
Am Surg; 1984 Dec; 50(12):663-5. PubMed ID: 6391313
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 protects against liver injury after Escherichia coli infection but hampers the resolution of the infection in mice.
Takano M; Nishimura H; Kimura Y; Washizu J; Mokuno Y; Nimura Y; Yoshikai Y
J Immunol; 1998 Sep; 161(6):3019-25. PubMed ID: 9743366
[TBL] [Abstract][Full Text] [Related]
17. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
[TBL] [Abstract][Full Text] [Related]
18. [Immunostimulant treatments].
Herman D; Roger M
Rev Prat; 1978 Sep; 28(41):3105-12, 3115-7. PubMed ID: 715349
[No Abstract] [Full Text] [Related]
19. Preventing bacterial infection by coordinating antibiotic and host activity: a time-dependent relationship.
Burke JF
South Med J; 1977 Oct; 70 Suppl 1():24-6. PubMed ID: 910185
[No Abstract] [Full Text] [Related]
20. Enhancement of host defence by Y-19995 (2,4'-bis(1-methyl-2-dimethyl-aminoethoxyl)-3-benzoylpyridine dimaleate), a novel synthetic compound. I. Accelerated restoration from the leukocytopenia and augmented protection against microbial infections in immunocompromised mice.
Fujisawa H; Tsuru S; Hisatome M; Goto K; Oe T; Okumoto T; Taniguchi M; Nomoto K
J Clin Lab Immunol; 1987 Aug; 23(4):203-8. PubMed ID: 3312612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
